- EQS-Adhoc: BB Biotech AG publishes its interim report
- EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
- EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
- EQS-DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
- EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
- EQS-News: Investor interest returns – dividend yield remains high for 2024
More ▼
Key statistics
On Tuesday, BB Biotech AG (BION:SWX) closed at 41.35, 16.97% above the 52 week low of 35.35 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 55.40m |
---|---|
Market cap | 2.29bn CHF |
Total assets | 2.38bn CHF |
Total expense ratio | 1.43% |
High | 41.50 |
Low | 41.00 |
Previous close | 41.35 |
Average volume | 66.60k |
---|---|
YTD Change | -3.27% |
Beta | 1.2087 |
Diluted NAV (est) | 42.90 |
Diluted NAV (last pub) | 42.90 |
Premium/Discount | -- |
Net Gearing | 0.00% |
Annual div (ADY) | 2.00 CHF |
---|---|
Annual div yield (ADY) | 4.84% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 15 minutes, as of Apr 30 2024 16:31 BST.
More ▼